JP Patent

JP6283337B2 — （２ｓ，３ｒ，４ｒ，５ｓ，６ｒ）−２−（４−クロロ−３−（４−エトキシベンジル）フェニル）−６−（メチルチオ）テトラヒドロ−２ｈ−ピラン−３，４，５−トリオールの固体形態及びその使用方法

Assigned to レクシコン ファーマシューティカルズ インコーポレイテッド · Expires 2018-02-21 · 8y expired

What this patent protects

Patent listed against Inpefa.

Drugs covered by this patent

Patent Metadata

Patent number
JP6283337B2
Jurisdiction
JP
Classification
—
Expires
2018-02-21
Drug substance claim
No
Drug product claim
No
Assignee
レクシコン ファーマシューティカルズ インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.